NXLIW — Nexalin Technology, Inc.
Healthcare • Medical - Devices
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a...…
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $0.02
- Day High
- $0.01
- Day Low
- $0.01
- 52w High
- $0.01
- 52w Low
- $0.01
- Volume
- 122,671
- Avg Volume
- Beta
- 3.8
* TTM/most recent where available
Company
- Ticker
- NXLIW
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- CEO
- Mark White
- Employees
- 6
- Website
- www.nexalin.com
Key Metrics
- Market Cap
- 11.2M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).